Next Article in Journal
Adverse Drug Reactions to SGLT2i Reported by Type 2 Diabetes New Users: An Active Surveillance Study
Next Article in Special Issue
In Vivo PK-PD and Drug–Drug Interaction Study of Dorzagliatin for the Management of PI3Kα Inhibitor-Induced Hyperglycemia
Previous Article in Journal
Regulatory Perspectives for AI/ML Implementation in Pharmaceutical GMP Environments
 
 
Article

Article Versions Notes

Pharmaceuticals 2025, 18(6), 903; https://doi.org/10.3390/ph18060903
Action Date Notes Link
article pdf uploaded. 16 June 2025 16:14 CEST Version of Record -
article supplementary file uploaded. 16 June 2025 16:14 CEST - https://www.mdpi.com/1424-8247/18/6/903#supplementary
article pdf uploaded. 17 June 2025 08:09 CEST Updated version of record -
article xml file uploaded 17 June 2025 08:19 CEST Original file -
article xml uploaded. 17 June 2025 08:19 CEST Update -
article pdf uploaded. 17 June 2025 08:19 CEST Updated version of record -
article html file updated 17 June 2025 08:21 CEST Original file -
article xml file uploaded 17 June 2025 09:16 CEST Update -
article xml uploaded. 17 June 2025 09:16 CEST Update https://www.mdpi.com/1424-8247/18/6/903/xml
article pdf uploaded. 17 June 2025 09:16 CEST Updated version of record https://www.mdpi.com/1424-8247/18/6/903/pdf
article html file updated 17 June 2025 09:21 CEST Update -
article html file updated 25 June 2025 09:55 CEST Update https://www.mdpi.com/1424-8247/18/6/903/html
Back to TopTop